Update meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: evidence from 25 studies

Gene. 2013 Jun 1;521(2):252-8. doi: 10.1016/j.gene.2013.03.079. Epub 2013 Apr 2.

Abstract

Background: The matrix metalloproteinase (MMP) can degrade various components of the extracellular matrix and its functional genetic polymorphism may be associated with cancer development. The common MMP-7 (-181A>G) genetic polymorphism has been reported to be functional and may contribute to genetic susceptibility to cancers. However, the association between MMP-7 (-181A>G) and cancer risk remains inconclusive.

Methods: To better understand the role of MMP-7 (-181A>G) polymorphism in global cancer, we conducted this comprehensive meta-analysis encompassing 6392 cases and 7665 controls.

Results: Overall, the MMP-7 (-181A>G) polymorphism was associated with higher cancer risk. In the stratified analyses, significant associations were found between the MMP-7 (-181A>G) polymorphism and gastric cancer, ESCC and gynecologic cancer. We also observed that the GG genotype might modulate colorectal cancer risk comparing with the AA genotype (OR=1.31[1.02-1.69]). Moreover, a significantly increased cancer risk was found among Asian populations. When stratified by study design, significantly elevated susceptibility to cancer was found among population-based studies.

Conclusions: These findings suggested that the MMP-7 (-181A>G) genetic polymorphism may contribute to the susceptibility of cancers, especially among Asian population.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People
  • Case-Control Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Matrix Metalloproteinase 7 / genetics*
  • Neoplasms / enzymology*
  • Neoplasms / genetics*
  • Polymorphism, Genetic
  • Risk

Substances

  • MMP7 protein, human
  • Matrix Metalloproteinase 7